Publication | Open Access

North Central Cancer Treatment Group Phase I Trial N057K of Everolimus (RAD001) and Temozolomide in Combination With Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme

Neuro-oncologyTrial N057kRadiation MedicineRadiation TherapyGliomaGlioblastoma MultiformeMedicineHigh-grade GliomasCancer TreatmentOncologyRadiation OncologyRadiologyHealth Sciences